bromopyruvate has been researched along with Disease Models, Animal in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (14.29) | 29.6817 |
2010's | 12 (57.14) | 24.3611 |
2020's | 6 (28.57) | 2.80 |
Authors | Studies |
---|---|
Abe, F; Ikeda, S; Kitadate, A; Matsuda, Y; Tagawa, H; Takahashi, N | 1 |
Anastasiadou, E; Balafas, E; Basogianni, AS; Konstantakou, EG; Kostomitsopoulos, N; Paronis, E; Stravopodis, DJ; Syrigos, KN; Velentzas, AD; Voutsinas, GE | 1 |
Bao, BY; Chen, YR; Cheng, WC; Chiu, CC; Chung, WJ; Chuu, CP; Huang, SP; Ke, CC; Lee, CH; Li, CY; Liu, PL; Su, CC; Wang, SC; Wu, HE; Wu, YH; Yeh, HC | 1 |
Darvishi, P; Pourfathollah, AA; Yousefi, S; Yousefi, Z | 1 |
Ibrahim, WM; Mansour, MA; Salama, AF; Salama, MM | 1 |
Guo, Y; He, Y; Liu, X; Ouyang, F; Qiu, H; Zhang, Y | 1 |
Chang, L; Li, X; Liang, C; Wang, W; Yu, H; Zhu, J | 1 |
Arandjelovic, S; Bullock, TNJ; Gaultier, A; Gemta, L; Rosen, AM; Seki, SM; Stevenson, M | 1 |
Casal, M; Ko, YH; Niedźwiecka, K; Pedersen, PL; Ułaszewski, S | 1 |
He, YY; Huang, KY; Jing, ZC; Shen, YF; Zhang, R; Zhang, YL; Zhao, JH | 1 |
Boradia, VM; Chopra, S; Das, S; Dasgupta, A; Gani, Z; Kumar, A; Patidar, A; Raje, CI; Raje, M; Singh, AK; Thakare, R | 1 |
Chapiro, J; Duran, R; Ewald, AJ; Ganapathy-Kanniappan, S; Geschwind, JF; Herman, JM; Lin, M; Luo, W; Moats, CR; Reyes, J; Savic, LJ; Semenza, GL; Sur, S; Thiruganasambandam, SC; Tran, PT; Vogelstein, B | 1 |
Jin, Q; Li, Q; Liu, H; Pan, Q; Sun, Y; Wang, Q; Zhao, S | 1 |
Morinobu, A; Nishimura, K; Okano, T; Saegusa, J; Sendo, S; Takahashi, S; Ueda, Y | 1 |
Acha-Ngwodo, O; Buijs, M; Engles, JM; Geschwind, JF; Ishimori, T; Vali, M; Vossen, JA; Wahl, RL | 1 |
Buijs, M; Geschwind, JF; Kutiyanwala, F; Kutiyanwala, M; Syed, L; Vali, M; Vossen, JA | 1 |
Abou El-Magd, RM; Chung, SP; El Sayed, SM; Fukui, K; Kagami, S; Sakai, T; Shishido, Y; Watanabe, H | 1 |
Buchanan, JW; Engles, J; Geschwind, JF; Schaefer, NG; Wahl, RL | 1 |
Goldberg, SN | 1 |
Buijs, M; Carson, KA; Ganapathy-Kanniappan, S; Geschwind, JF; Kunjithapatham, R; Rao, PP; Torbenson, MS; Vali, M | 1 |
Georgiades, C; Geschwind, JF; Hong, K; Khwaja, A; Kowalski, J; Liapi, E; Torbenson, MS; Vali, M | 1 |
21 other study(ies) available for bromopyruvate and Disease Models, Animal
Article | Year |
---|---|
Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myeloma.
Topics: Animals; Apoptosis; Autophagy; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glycolysis; Hexokinase; Humans; Hypoxia; Mice; Multiple Myeloma; Pyruvates; Stress, Physiological; Xenograft Model Antitumor Assays | 2020 |
3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants.
Topics: Animals; Apoptosis; Autophagy; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Energy Metabolism; Gene Silencing; Glucose; Glucose Transporter Type 4; Humans; Mice; Mitogen-Activated Protein Kinases; Pinocytosis; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Pyruvates; RNA Splicing; Signal Transduction; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Male; Mice; Prostatic Neoplasms, Castration-Resistant; Pyruvates; Xenograft Model Antitumor Assays | 2022 |
Effect of methyl jasmonate and 3-bromopyruvate combination therapy on mice bearing the 4 T1 breast cancer cell line.
Topics: Acetates; Affinity Labels; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Disease Models, Animal; Female; Mice; Oxylipins; Plant Growth Regulators; Pyruvates; Xenograft Model Antitumor Assays | 2020 |
Dual inhibition of glycolysis and autophagy as a therapeutic strategy in the treatment of Ehrlich ascites carcinoma.
Topics: Animals; Antineoplastic Agents; Antioxidants; Autophagy; Carcinoma, Ehrlich Tumor; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Female; Glycolysis; Hexokinase; Hydroxychloroquine; Kupffer Cells; Liver; Mice; Mice, Inbred BALB C; Oxidative Stress; Pyruvates | 2020 |
3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism.
Topics: Animals; Disease Models, Animal; Male; Mitochondria; Monocrotaline; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pulmonary Arterial Hypertension; Pulmonary Artery; Pyruvates; Rats; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases | 2020 |
3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model.
Topics: Animals; Cell Line; Cell Proliferation; China; Disease Models, Animal; Fibroblasts; Fibrosis; Glycolysis; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Myofibroblasts; Pyruvates; Rats; Signal Transduction; Transforming Growth Factor beta1; Ureteral Obstruction; Urinary Tract | 2021 |
Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Central Nervous System; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Glycolysis; Interferon-gamma; Interleukin-17; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Pyruvates; Th1 Cells; Th17 Cells | 2017 |
3-Bromopyruvate as a potent anticancer therapy in honor and memory of the late Professor André Goffeau.
Topics: Animals; Antineoplastic Agents; Apoptosis; Disease Models, Animal; Fungi; Glycolysis; Hexokinase; Humans; Melanoma; Mitochondria; Multiple Myeloma; Neoplasms; Pyruvates; Pyruvic Acid | 2019 |
3-Bromopyruvate Attenuates Experimental Pulmonary Hypertension via Inhibition of Glycolysis.
Topics: Animals; Apoptosis; Cardiac Catheterization; Disease Models, Animal; Enzyme Inhibitors; Glycolysis; Hypertension, Pulmonary; Immunohistochemistry; Male; Pulmonary Wedge Pressure; Pyruvates; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vascular Resistance | 2019 |
Repurposing ethyl bromopyruvate as a broad-spectrum antibacterial.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Repositioning; Enzyme Inhibitors; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Mice, Inbred BALB C; Microbial Viability; Mycobacterium tuberculosis; Pyruvates; Staphylococcal Infections; Staphylococcus aureus; Transferrin; Treatment Outcome | 2019 |
Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer.
Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Cell Line, Tumor; Cell Movement; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Compounding; Humans; Male; Mice; Pancreatic Neoplasms; Pyruvates; Spheroids, Cellular; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice.
Topics: Acute Kidney Injury; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Kidney; Liver; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Pyruvates | 2016 |
3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell differentiation and suppressing dendritic cell activation.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmune Diseases; Cell Differentiation; Dendritic Cells; Disease Models, Animal; Disease Progression; Hexokinase; Lymphocyte Activation; Lymphocyte Count; Mice; Pyruvates; Synovial Membrane; T-Lymphocytes, Regulatory; Th17 Cells | 2017 |
Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glycolysis; Mammary Neoplasms, Experimental; Pyruvates; Rats; Rats, Inbred Lew | 2009 |
Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.
Topics: Animals; Chemoembolization, Therapeutic; Disease Models, Animal; Hepatectomy; Infusions, Intra-Arterial; Liver Neoplasms, Experimental; Lung Neoplasms; Pyruvates; Rabbits | 2008 |
D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate.
Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; D-Amino-Acid Oxidase; Disease Models, Animal; Enzyme Inhibitors; Female; Genetic Therapy; Glioblastoma; Glioma; Glycolysis; Humans; Hydrogen Peroxide; Mice; Neoplastic Stem Cells; Oxidative Stress; Pyruvates; Rats; Rats, Sprague-Dawley; Transfection | 2012 |
Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Glycolysis; Humans; Lethal Dose 50; Lymphoma, Non-Hodgkin; Male; Mice; Mice, SCID; Pyruvates; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2012 |
Science to practice: what do molecular biologic studies in rodent models add to our understanding of interventional oncologic procedures including percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists?
Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Liver Neoplasms; Proto-Oncogene Mas; Pyruvates; RNA, Small Interfering | 2012 |
Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Injections; Liver Neoplasms; Luminescent Measurements; Mice; Mice, Nude; Proto-Oncogene Mas; Proto-Oncogene Proteins c-jun; Pyruvates; Real-Time Polymerase Chain Reaction; RNA, Small Interfering | 2012 |
Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer.
Topics: Animals; Antineoplastic Agents; Catheterization; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hepatic Artery; Infusions, Intra-Arterial; Injections, Intra-Arterial; Liver Neoplasms, Experimental; Maximum Tolerated Dose; Pyruvate Dehydrogenase Complex; Pyruvates; Rabbits | 2007 |